Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.37 |
| ▸ | ESR1 | P03372 | 2/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | HTR1A | P08908 | 2/20 | 0.37 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.37 |
| ▸ | ACHE | P22303 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 2/20 | 0.34 |
| ▸ | RAB9A | P51151 | 2/20 | 0.34 |
| ▸ | ELANE | P08246 | 1/20 | 0.34 |
| ▸ | HTR1D | P28221 | 1/20 | 0.34 |
| ▸ | HTR1B | P28222 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.33 |
| ▸ | RELA | Q04206 | 1/20 | 0.33 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9824924 | 0.86 | ALDH1A1 (0.38) | SMN1; SMN2ESR1KMT2AALDH1A1KDM4E | |
| SCHEMBL4060537 | 0.85 | TBXAS1 (0.39) | SMN1; SMN2KMT2AALDH1A1KDM4ENPC1 | |
| SCHEMBL5060773 | 0.83 | KMT2A (0.41) | SMN1; SMN2KMT2ARECQLHTR1AKDM4E | |
| SCHEMBL16859466 | 0.81 | TBXAS1 (0.33) | SMN1; SMN2ALDH1A1KDM4ENPC1RAB9A | |
| SCHEMBL11589157 | 0.81 | TBXAS1 (0.44) | SMN1; SMN2KMT2AALDH1A1KDM4ENPC1 | |
| SCHEMBL25475176 | 0.81 | TBXAS1 (0.33) | SMN1; SMN2ALDH1A1KDM4ENPC1RAB9A | |
| SCHEMBL16859448 | 0.81 | TBXAS1 (0.33) | SMN1; SMN2ALDH1A1KDM4ENPC1RAB9A | |
| SCHEMBL11048265 | 0.81 | TBXAS1 (0.33) | SMN1; SMN2ALDH1A1KDM4ENPC1RAB9A | |
| SCHEMBL16859463 | 0.81 | TBXAS1 (0.33) | SMN1; SMN2KMT2AALDH1A1KDM4ENPC1 | |
| SCHEMBL9825273 | 0.81 | NPC1 (0.38) | SMN1; SMN2ALDH1A1KDM4ENPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 333 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121528553-B | Sepsis myocardial function prognosis prediction method based on imidazole propionic acid targeted intervention | Zhoupu Hospital, Pudong New Area, Shanghai (Zhoupu Hospital Affiliated to Shanghai Medical College) (CN) | 2026-05-26 | — | — | CN | claimed |
| US-20260076944-A1 | COMPOSITIONS AND METHODS FOR PROMOTING BRAIN HEALTH | UNIV CALIFORNIA (US) | 2026-03-19 | — | — | US | claimed |
| US-12491217-B2 | Compositions and methods for promoting healthy neural development in an unborn baby | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-12-09 | — | — | US | claimed |
| US-12292445-B2 | Methods of selecting subjects for treatment with metabolomic modulators | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-05-06 | — | — | US | claimed |
| CN-118685743-A | Preparation and surface treatment method of high-strength and high-peeling-resistance carrier copper foil | 安徽铜冠铜箔集团股份有限公司 | 2024-09-24 | — | — | CN | claimed |
| CN-118265532-A | Methods and uses of microbiome compositions, components or metabolites for treating neurodegenerative diseases | 奇迹生物公司 | 2024-06-28 | — | — | CN | claimed |
| CN-118258878-A | Blood urine metabolism marker, disease diagnosis and typing system | 复旦大学附属中山医院 | 2024-06-28 | — | — | CN | claimed |
| CN-117598247-A | Application of imidazole propionic acid in preparation of modeling agent for inducing ulcerative colitis animal model | 天津中医药大学 | 2024-02-27 | — | — | CN | claimed |
| US-20230375534-A1 | MEANS AND METHODS TO DIAGNOSE GUT FLORA DYSBIOSIS AND INFLAMMATION | VIB VZW (BE) | 2023-11-23 | — | — | US | claimed |
| CN-116990395-A | Alzheimer disease biomarker based on feces and application thereof | 中国科学院深圳先进技术研究院 | 2023-11-03 | — | — | CN | claimed |
| EP-2890808-A2 | DIAGNOSIS AND TREATMENT OF AUTISM SPECTRUM DISORDER | California Institute of Technology (US) | 2015-07-08 | — | — | EP | claimed |
| US-20140065132-A1 | DIAGNOSIS AND TREATMENT OF AUTISM SPECTRUM DISORDER | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2014-03-06 | — | — | US | claimed |
| WO-2014036182-A2 | DIAGNOSIS AND TREATMENT OF AUTISM SPECTRUM DISORDER | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2014-03-06 | — | — | WO | claimed |
| JP-3759748-B2 | — | — | 2006-03-29 | — | — | JP | claimed |
| EP-0736038-B1 | COMPOUNDS WITH GROWTH HORMONE RELEASING PROPERTIES | NOVO NORDISK AS (DK) | 2001-07-04 | — | — | EP | claimed |
| CN-1052730-C | Compounds with growth hormone releasing properties | NOVO NORDISK AS (DK) | 2000-05-24 | — | — | CN | claimed |
| US-5854211-A | Compounds with growth hormone releasing properties | NOVO NORDISK A/S (DK) | 1998-12-29 | — | — | US | claimed |
| CN-1138334-A | Compounds with growth hormone releasing properties | NOVO NORDISK AS (DK) | 1996-12-18 | — | — | CN | claimed |
| EP-0736038-A1 | COMPOUNDS WITH GROWTH HORMONE RELEASING PROPERTIES | NOVO NORDISK A/S (DK) | 1996-10-09 | — | — | EP | claimed |
| WO-1995017422-A1 | COMPOUNDS WITH GROWTH HORMONE RELEASING PROPERTIES | NOVO NORDISK A/S (DK) | 1995-06-29 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260076944-A1 | COMPOSITIONS AND METHODS FOR PROMOTING BRAIN HEALTH | IDO1, INMT, IDO2 | SMN1; SMN2 1923/4885ESR1 4592/4885HIF1A 548/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.